HIV AIDS classification: Difference between revisions
m (Bot: Removing from Primary care) |
|||
(49 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{AIDS}} | {{AIDS}} | ||
{{CMG}} ; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Many definitions have been developed for [[epidemiology|epidemiological]] surveillance of HIV/AIDS such as the ''Bangui definition'' and the ''1994 Expanded World Health Organization AIDS Case Definition''. However, these systems are neither sensitive nor specific for clinical staging. In developing countries, the [[World Health Organization]] staging system for HIV infection and disease that uses clinical and laboratory data is widely employed. The [[Centers for Disease Control and Prevention|Centers for Disease Control]] (CDC) Classification System for HIV/AIDS is another primary system used that is primarily based on [[T helper cells|CD4 T-lymphocyte]] counts. | |||
==Classification== | ==Classification== | ||
=== WHO | ===WHO Staging System for HIV Infection and Disease in Adults and Adolescents<ref name=who>WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006.</ref>=== | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width:950px " align=center | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Clinical stage}} | ! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Clinical stage}} | ||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Features}} | ! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Features}} | ||
Line 43: | Line 27: | ||
*Papular pruritic eruptions | *Papular pruritic eruptions | ||
*Angular cheilitis | *Angular cheilitis | ||
* | *Seborrhoeic [[dermatitis]] | ||
*Fungal [[finger nail]] [[infections]] | *Fungal [[finger nail]] [[infections]] | ||
|- | |- | ||
Line 51: | Line 35: | ||
'''''Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations''''' | '''''Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations''''' | ||
*Unexplained chronic diarrhoea for longer than one month | *Unexplained chronic [[diarrhoea]] for longer than one month | ||
*Unexplained persistent fever (intermittent or constant for longer than one month) | *Unexplained persistent [[fever]] (intermittent or constant for longer than one month) | ||
*Severe weight loss (>10% of presumed or measured body weight) | *Severe [[weight loss]] (>10% of presumed or measured body weight) | ||
*Oral [[candidiasis]] | *Oral [[candidiasis]] | ||
*Oral hairy [[leukoplakia]] | *Oral hairy [[leukoplakia]] | ||
*[[Pulmonary tuberculosis]] (TB) diagnosed in last two years | *[[Pulmonary tuberculosis]] (TB) diagnosed in last two years | ||
*Severe presumed bacterial infections (e.g. pneumonia, empyema, meningitis, bacteraemia, pyomyositis, bone or joint infection) | *Severe presumed bacterial [[infections]] (e.g. [[pneumonia]], [[empyema]], [[meningitis]], [[bacteraemia]], [[pyomyositis]], [[bone]] or [[joint]] [[infection]]) | ||
*Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis | *Acute necrotizing ulcerative [[stomatitis]], [[gingivitis]] or [[periodontitis]] | ||
'''''Conditions where confirmatory diagnostic testing is necessary''''' | '''''Conditions where confirmatory diagnostic testing is necessary''''' | ||
*Unexplained anaemia (< 80 g/l), and or neutropenia (<500/µl) and or thrombocytopenia (<50 000/ µl) for more than one month | *Unexplained [[anaemia]] (< 80 g/l), and or [[neutropenia]](<500/µl) and or [[thrombocytopenia]] (<50 000/ µl) for more than one month | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 4 | | style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 4 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
'''''Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations''''' | '''''Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations''''' | ||
*HIV wasting syndrome | *HIV [[wasting syndrome]] | ||
*Pneumocystis pneumonia | *[[Pneumocystis pneumonia]] | ||
*Recurrent severe or radiological bacterial pneumonia | *Recurrent severe or radiological bacterial [[pneumonia]] | ||
*Chronic herpes simplex infection (orolabial, genital or anorectal of more than one month’s duration) | *Chronic [[herpes]] simplex [[infection]] (orolabial, genital or anorectal of more than one month’s duration) | ||
*Oesophageal candidiasis | *Oesophageal [[candidiasis]] | ||
*Extrapulmonary Tuberculosis | *Extrapulmonary [[Tuberculosis]] | ||
* | *[[Kaposi sarcoma]] | ||
*Central nervous system toxoplasmosis | *Central nervous system [[toxoplasmosis]] | ||
*HIV encephalopathy | *HIV [[encephalopathy]] | ||
'''''Conditions where confirmatory diagnostic testing is necessary''''' | '''''Conditions where confirmatory diagnostic testing is necessary''''' | ||
*Extrapulmonary cryptococcosis including meningitis | *Extrapulmonary [[cryptococcosis]] including [[meningitis]] | ||
*Disseminated non-tuberculous mycobacteria infection | *Disseminated non-tuberculous mycobacteria [[infection]] | ||
*Progressive multifocal leukoencephalopathy | *[[Progressive multifocal leukoencephalopathy]] | ||
*Candida of trachea, bronchi or lungs | *[[Candida]] of [[trachea]], [[bronchi]] or [[lungs]] | ||
*Cryptosporidiosis | *[[Cryptosporidiosis]] | ||
*Isosporiasis | *[[Isosporiasis]] | ||
*Visceral herpes simplex infection | *Visceral [[herpes]] simplex infection | ||
*Cytomegalovirus ([[CMV]]) infection (retinitis or of an organ other than liver, spleen or lymph nodes) | *[[Cytomegalovirus]] ([[CMV]]) [[infection]] ([[retinitis]] or of an organ other than [[liver]], [[spleen]] or [[lymph nodes]]) | ||
*Any disseminated mycosis (e.g. histoplasmosis, coccidiomycosis, penicilliosis) | *Any disseminated [[mycosis]] (e.g. [[histoplasmosis]], [[coccidiomycosis]], [[penicilliosis]]) | ||
*Recurrent non-typhoidal salmonella septicaemia | *Recurrent non-typhoidal [[salmonella]] septicaemia | ||
*Lymphoma (cerebral or B cell non-Hodgkin) | *[[Lymphoma]] (cerebral or B cell non-Hodgkin) | ||
*Invasive cervical carcinoma | *Invasive [[cervical carcinoma]] | ||
*Visceral leishmaniasis | *Visceral [[leishmaniasis]] | ||
|} | |} | ||
===WHO | ===WHO Staging System for HIV Infection and Disease in Children (Revised 2006) <ref name=who>WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006.</ref>=== | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width:950px;" align=center | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Clinical stage}} | ! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Clinical stage}} | ||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Features}} | ! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Features}} | ||
Line 105: | Line 88: | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 2 | | style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 2 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*[[Hepatosplenomegaly]] | |||
*Papular pruritic eruptions | |||
*[[Seborrhoeic dermatitis]] | |||
*Extensive human papilloma virus infection | |||
*Extensive [[molluscum contagiosum]] | |||
*Fungal nail [[infections]] | |||
*Recurrent [[oral ulcerations]] | |||
*Linear gingival erythema (LGE) | |||
*Angular [[cheilitis]] | |||
*[[Parotid]] enlargement | |||
*[[Herpes zoster]] | |||
*Recurrent or chronic RTIs (otitis media, otorrhoea, sinusitis) | |||
*Chronic [[diarrhoea]] lasting for more than 30 days in the absence of known etiology | *Chronic [[diarrhoea]] lasting for more than 30 days in the absence of known etiology | ||
*Severe persistent or recurrent [[candidiasis]] outside the neonatal period | *Severe persistent or recurrent [[candidiasis]] outside the neonatal period | ||
Line 113: | Line 108: | ||
| style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 3 | | style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 3 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
'''''Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations''''' | |||
*Moderate unexplained [[malnutrition]] not adequately responding to standard therapy | |||
*Unexplained persistent [[diarrhoea]] (14 days or more ) | |||
*Unexplained persistent [[fever]] (intermittent or constant, for longer than one month) | |||
*Oral [[candidiasis]] (outside neonatal period ) | |||
*Oral hairy [[leukoplakia]] | |||
*Acute necrotizing ulcerative [[gingivitis]]/[[periodontitis]] | |||
*[[Pulmonary TB]] | |||
*Severe recurrent presumed bacterial pneumonia | |||
'''''Conditions where confirmatory diagnostic testing is necessary''''' | |||
*Chronic HIV-associated lung disease including [[brochiectasis]] | |||
*Lymphoid interstitial [[pneumonitis]] (LIP) | |||
*Unexplained [[anaemia]] (<80g/l), and or [[neutropenia]] (<1000/µl) and or [[thrombocytopenia]] (<50 000/µl) for more than one month | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |Clinical stage 4 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
'''''Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations''''' | |||
*Unexplained severe wasting or severe [[malnutrition]] not adequately responding to standard therapy | |||
*[[Pneumocystis pneumonia]] | |||
*Recurrent severe presumed bacterial [[infections]] (e.g. [[empyema]], [[pyomyositis]], [[bone]] or joint infection, [[meningitis]], but excluding [[pneumonia]]) | |||
*Chronic [[herpes simplex]] infection; (orolabial or cutaneous of more than one month’s duration) | |||
*Extrapulmonary [[Tuberculosis]] | |||
*Kaposi’s sarcoma | |||
*Oesophageal [[candidiasis]] | |||
*Central nervous system [[toxoplasmosis]] (outside the neonatal period) | |||
*HIV [[encephalopathy]] | |||
'''''Conditions where confirmatory diagnostic testing is necessary''''' | |||
*[[CMV]] infection (CMV retinitis or infection of organs other than liver, spleen or lymph nodes; onset at age one month or more) | |||
*Extrapulmonary cryptococcosis including meningitis | |||
*Any disseminated endemic mycosis (e.g. extrapulmonary histoplasmosis, coccidiomycosis, penicilliosis) | |||
*[[Cryptosporidiosis]] | |||
*[[Isosporiasis]] | |||
*Disseminated non-tuberculous mycobacteria infection | |||
*[[Candida]] of trachea, bronchi or lungs | |||
*Visceral herpes simplex infection | |||
*Acquired [[HIV]] associated rectal fistula | |||
*Cerebral or B cell [[non-Hodgkin lymphoma]] | |||
*[[Progressive multifocal leukoencephalopathy]] (PML) | |||
*HIV-associated [[cardiomyopathy]] or HIV-associated [[nephropathy]] | |||
|} | |||
==CDC Classification System== | |||
The table below shows the HIV infection stage, based on age-specific CD4+ T-lymphocyte count or CD4+ T-lymphocyte percentage of total lymphocytes. <ref> {{cite web| url=http://www.cdc.gov/hiv/statistics/recommendations/terms.html| title=CDC HIV/AIDS Surveillance Publications}}</ref> | |||
}} | {{#widget:BlueTable}} | ||
{|class="BlueTable" style="width: 500px" | |||
!rowspan=3|Stage* | |||
!colspan=6|Age on date of CD4 T-lymphocyte test | |||
|- | |||
! colspan=2|<1 year | |||
! colspan=2|1—5 years | |||
! colspan=2|6 years through adult | |||
|- | |||
! Cells/µL||%||Cells/µL||%||Cells/µL||% | |||
|- | |||
| 1||≥1,500||≥34||≥1,000||≥30||≥500||≥26 | |||
|- | |||
| 2||750—1,499||26—33||500—999||22—29||200—499||14—25 | |||
|- | |||
| 3||<750||<26||<500||<22||<200||<14 | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |colspan=7|<small> *The stage is based primarily on the CD4+ T-lymphocyte count; the CD4+ T-lymphocyte count takes precedence over the CD4 T-lymphocyte percentage, and the percentage is considered only if the count is missing.</small> | ||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:HIV/AIDS]] | [[Category:HIV/AIDS]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Immune system disorders]] | [[Category:Immune system disorders]] | ||
[[Category: | [[Category:Viral diseases]] | ||
[[Category:Pandemics]] | [[Category:Pandemics]] | ||
[[Category:Sexually transmitted infections]] | [[Category:Sexually transmitted infections]] | ||
Line 206: | Line 194: | ||
[[Category:Immunodeficiency]] | [[Category:Immunodeficiency]] | ||
[[Category:Microbiology]] | [[Category:Microbiology]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] |
Latest revision as of 22:11, 29 July 2020
AIDS Microchapters |
Diagnosis |
Treatment |
Case Studies |
HIV AIDS classification On the Web |
American Roentgen Ray Society Images of HIV AIDS classification |
Risk calculators and risk factors for HIV AIDS classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Many definitions have been developed for epidemiological surveillance of HIV/AIDS such as the Bangui definition and the 1994 Expanded World Health Organization AIDS Case Definition. However, these systems are neither sensitive nor specific for clinical staging. In developing countries, the World Health Organization staging system for HIV infection and disease that uses clinical and laboratory data is widely employed. The Centers for Disease Control (CDC) Classification System for HIV/AIDS is another primary system used that is primarily based on CD4 T-lymphocyte counts.
Classification
WHO Staging System for HIV Infection and Disease in Adults and Adolescents[1]
Clinical stage | Features |
---|---|
Clinical stage 1 |
|
Clinical stage 2 |
|
Clinical stage 3 |
Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations
Conditions where confirmatory diagnostic testing is necessary
|
Clinical stage 4 |
Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations
Conditions where confirmatory diagnostic testing is necessary
|
WHO Staging System for HIV Infection and Disease in Children (Revised 2006) [1]
Clinical stage | Features |
---|---|
Clinical stage 1 |
|
Clinical stage 2 |
|
Clinical stage 3 |
Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations
Conditions where confirmatory diagnostic testing is necessary
|
Clinical stage 4 |
Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations
Conditions where confirmatory diagnostic testing is necessary
|
CDC Classification System
The table below shows the HIV infection stage, based on age-specific CD4+ T-lymphocyte count or CD4+ T-lymphocyte percentage of total lymphocytes. [2]
Stage* | Age on date of CD4 T-lymphocyte test | |||||
---|---|---|---|---|---|---|
<1 year | 1—5 years | 6 years through adult | ||||
Cells/µL | % | Cells/µL | % | Cells/µL | % | |
1 | ≥1,500 | ≥34 | ≥1,000 | ≥30 | ≥500 | ≥26 |
2 | 750—1,499 | 26—33 | 500—999 | 22—29 | 200—499 | 14—25 |
3 | <750 | <26 | <500 | <22 | <200 | <14 |
*The stage is based primarily on the CD4+ T-lymphocyte count; the CD4+ T-lymphocyte count takes precedence over the CD4 T-lymphocyte percentage, and the percentage is considered only if the count is missing. |
References
- ↑ 1.0 1.1 WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006.
- ↑ "CDC HIV/AIDS Surveillance Publications".